severe pre-eclampsia
Information
- Disease name
- severe pre-eclampsia
- Disease ID
- DOID:13129
- Description
- "A pre-eclampsia that has_symptom at least one of the following: SBP of 160mm HG or higher or DPB of 110mm HG or higher on 2 occasions at least 6 hours apart, proteinuria more than 5g in a 24-hour collection, pulmonary edema or cyanosis, oliguria, persistent headaches, epigastric pain and/or impaired liver function, thrombocytopenia, oligohydramnios, decreased fetal growth or placental abruption." [url:https\://www.ncbi.nlm.nih.gov/pubmed/25373431, url:https\://www.ncbi.nlm.nih.gov/pubmed/28793357]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05310929 | Completed | N/A | Nitroglycerin Versus Labetalol in Acute Severe Pre-eclampsia | August 28, 2019 | March 25, 2022 |
| NCT02164370 | Completed | Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach | October 2013 | October 2014 | |
| NCT01766089 | Completed | Phase 2 | Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery | January 2013 | January 2017 |
| NCT03661775 | Completed | N/A | Serum Magnesium Level Administration in Severe Pre-eclampsia Obese Pregnancy | September 30, 2018 | May 31, 2019 |
| NCT06126068 | Completed | N/A | Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia. | January 1, 2023 | June 30, 2023 |
| NCT06385600 | Not yet recruiting | N/A | Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia. | May 20, 2024 | March 20, 2026 |
| NCT05283473 | Recruiting | Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe Preeclampsia | March 15, 2022 | December 14, 2024 | |
| NCT06219109 | Recruiting | Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia | May 8, 2023 | April 2, 2024 | |
| NCT05176652 | Unknown status | Ultrasonographic Diameter of Optic Nerve Sheath in Fluid Assessment in Severe Preeclamptic Patients | December 6, 2021 | December 6, 2022 | |
| NCT02314286 | Unknown status | Phase 1/Phase 2 | Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery | December 2014 | July 2016 |
- Disase is a (Disease Ontology)
- DOID:10591
- Cross Reference ID (Disease Ontology)
- ICD9CM:642.50
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0156669
- Exact Synonym (Disease Ontology)
- antepartum severe pre-eclampsia
- Exact Synonym (Disease Ontology)
- postpartum severe pre-eclampsia
- Exact Synonym (Disease Ontology)
- Severe pre-eclampsia, with delivery
- Exact Synonym (Disease Ontology)
- severe preeclampsia
- ICD10 preferred id (Insert disease from ICD10)
- D0012121
- ICD10 class code (Insert disease from ICD10)
- O14.1